NL174251B - METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS BASED ON INDOOL DERIVATIVES, AND METHOD FOR PREPARING INDOOL DERIVATIVES - Google Patents

METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS BASED ON INDOOL DERIVATIVES, AND METHOD FOR PREPARING INDOOL DERIVATIVES

Info

Publication number
NL174251B
NL174251B NLAANVRAGE7200415,A NL7200415A NL174251B NL 174251 B NL174251 B NL 174251B NL 7200415 A NL7200415 A NL 7200415A NL 174251 B NL174251 B NL 174251B
Authority
NL
Netherlands
Prior art keywords
indool
derivatives
preparing
pharmaceutical preparations
preparations based
Prior art date
Application number
NLAANVRAGE7200415,A
Other languages
Dutch (nl)
Other versions
NL7200415A (en
NL174251C (en
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of NL7200415A publication Critical patent/NL7200415A/xx
Publication of NL174251B publication Critical patent/NL174251B/en
Application granted granted Critical
Publication of NL174251C publication Critical patent/NL174251C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
NLAANVRAGE7200415,A 1971-01-11 1972-01-11 METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS BASED ON INDOOL DERIVATIVES, AND METHOD FOR PREPARING INDOOL DERIVATIVES NL174251C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB125071*[A GB1366133A (en) 1971-01-11 1971-01-11 Fused ring indole derivatives
GB4095971 1971-09-02
GB5646771 1971-12-06

Publications (3)

Publication Number Publication Date
NL7200415A NL7200415A (en) 1972-07-13
NL174251B true NL174251B (en) 1983-12-16
NL174251C NL174251C (en) 1984-05-16

Family

ID=27253859

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7200415,A NL174251C (en) 1971-01-11 1972-01-11 METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS BASED ON INDOOL DERIVATIVES, AND METHOD FOR PREPARING INDOOL DERIVATIVES

Country Status (20)

Country Link
JP (1) JPS5531156B2 (en)
AR (1) AR192734A1 (en)
AT (1) AT312595B (en)
AU (1) AU464388B2 (en)
BE (1) BE777911A (en)
CA (1) CA1012150A (en)
CH (1) CH573938A5 (en)
CY (1) CY926A (en)
DK (1) DK150143C (en)
EG (1) EG10888A (en)
ES (2) ES398678A1 (en)
FI (1) FI54120C (en)
FR (1) FR2121699B1 (en)
GB (1) GB1366133A (en)
HK (1) HK52877A (en)
IE (1) IE35956B1 (en)
KE (1) KE2777A (en)
MY (1) MY7800048A (en)
NL (1) NL174251C (en)
SE (1) SE398645B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520611A (en) * 1976-06-11 1978-08-09 Wyeth John & Brother Ltd Fused ring indole derivatives
JPS5845741B2 (en) * 1977-06-06 1983-10-12 株式会社日立製作所 information retrieval device
ZA824382B (en) * 1981-07-07 1984-02-29 Wyeth John & Brother Ltd Anti-obesity agents
JPS60204057A (en) * 1984-03-28 1985-10-15 Casio Comput Co Ltd Small-sized electronic apparatus with data storage function
GB8606254D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
GB8606253D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Pyrimidoindoles
GB8614246D0 (en) * 1986-06-11 1986-07-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
WO2010090680A1 (en) * 2008-12-15 2010-08-12 Wyeth Llc Substituted oxindole cb2 agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888846A (en) * 1967-03-30 1975-06-10 Hoffmann La Roche Process for 2(2-(1,3-diazacycloalk-2-enyl))benzophenone derivatives and 1,3-diazacycloalkenyl(2,1-a)isoindole derivatives
US3586693A (en) * 1969-07-07 1971-06-22 American Home Prod Imidazo(1,2-a)indolin-9-ols

Also Published As

Publication number Publication date
SE398645B (en) 1978-01-09
FI54120B (en) 1978-06-30
AU3755872A (en) 1973-07-05
JPS4839500A (en) 1973-06-09
GB1366133A (en) 1974-09-11
CH573938A5 (en) 1976-03-31
HK52877A (en) 1977-10-20
FR2121699B1 (en) 1975-08-01
FI54120C (en) 1978-10-10
AR192734A1 (en) 1973-03-14
MY7800048A (en) 1978-12-31
DK150143C (en) 1987-06-01
EG10888A (en) 1978-06-30
ES409296A1 (en) 1976-03-16
IE35956B1 (en) 1976-07-07
KE2777A (en) 1977-10-21
CA1012150A (en) 1977-06-14
CY926A (en) 1977-12-23
NL7200415A (en) 1972-07-13
NL174251C (en) 1984-05-16
IE35956L (en) 1972-07-11
FR2121699A1 (en) 1972-08-25
BE777911A (en) 1972-07-11
AU464388B2 (en) 1975-08-28
JPS5531156B2 (en) 1980-08-15
AT312595B (en) 1974-01-10
DK150143B (en) 1986-12-15
ES398678A1 (en) 1975-05-16

Similar Documents

Publication Publication Date Title
NL173954C (en) METHOD FOR PREPARING 4-AMIDOPIPERIDINE COMPOUNDS AND METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS.
NL176468C (en) METHOD FOR PREPARING POLYETHERIMIDS AND FORMED PREPARATIONS MADE THEREOF
NL167993C (en) METHOD FOR PREPARING SPHERE-GRANULATED ENZYME PREPARATIONS.
NL184836C (en) PROCESS FOR PREPARING ANTI-INFLAMMATIC ACTIVE PHARMACEUTICAL PREPARATIONS AND METHOD FOR PREPARING ANTI-INFLAMMATIC ACTIVE OXAZOLOPYRIDINS.
NL168830B (en) METHOD FOR PREPARING THERAPEUTIC PREPARATIONS AND PROCESS FOR PREPARING AMIDS SUITABLE FOR THESE
NL7509667A (en) ENZYME PREPARATIONS AND METHOD FOR PREPARING SUCH PREPARATIONS.
NL171356C (en) METHOD FOR PREPARING 1,3-DIG SUBSTITUTED PROPAN-2-OL DERIVATIVES AND METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS.
NL178564C (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS BASED ON 1-SUBSTITUTED PYRAZOLONE-5 DERIVATIVES.
NL177917B (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS BASED ON 1-SUBSTITUTED PYRAZOLONE-5 DERIVATIVES, AND METHOD FOR PREPARING 1-SUBSTITUISED-PERSOZEDUZOLATED PYRAZOLATED PREPARATIONS.
NL177026C (en) METHOD FOR PREPARING MOLDABLE PREPARATIONS AND ARTICLES BASED ON SUCH MOLDABLE PREPARATIONS.
NL174251C (en) METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS BASED ON INDOOL DERIVATIVES, AND METHOD FOR PREPARING INDOOL DERIVATIVES
NL153514B (en) PROCESS FOR PREPARING DL-15-DEOXYPROSTAGLANDIN-E1, PROSTAGLANDINE-E1, D1-11-DEOXYPROSTAGLANDINE-E1 AND DL-11,15-DIDEOXYPROSTAGLANDINE-E1.
NL173167C (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS, BASED ON N-ACYLTRYPTOPHANE DERIVATIVES, AND METHOD FOR PREPARING N-ACYLTRYPTOPHANE DERIVATIVES.
NL165160C (en) PROCESS FOR PREPARING THIAZOLE DERIVATIVES, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND THE PRODUCTS PRODUCED THEREOF.
NL175827C (en) PROCESS FOR PREPARING ALFA- (5-INDANYLOXYCARBONYL) -BENZYLPENICILLIN AND PHARMACEUTICAL PREPARATIONS THEREOF
NL179535C (en) PROCESS FOR THE PREPARATION OF FUNGICIDE PREPARATIONS BASED ON FURANCARBOXAMIDE DERIVATIVES, THE FORMED FUNGICIDE PREPARATION, AND METHOD FOR PREPARING THESE FURANCARBOXAMIDE DERIVATIVES
NL7413424A (en) PROCEDURE FOR PREPARING 1,5-DINITRO-CHINONE AND 1,8-DINITROANTRACHINONE.
NL165163C (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS BASED ON N-PHENYLALKYL-3-THIENYL-3-ARYLPROPYLAMINE DERIVATIVES, FORMED PHARMACEUTICAL PREPARATIONS, AND 3-PHYPHYL-PREPARED-PREPARED-PREPARED PROPERTIES
NL142416B (en) PROCEDURE FOR PREPARING 6-AMINO-ACYLAMINOPENICILLAN ACIDS, AND PROCEDURE FOR PREPARING PHARMACEUTICAL PREPARATIONS.
NL174042C (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS BASED ON A 5-Substituted-5-FENYLALKYLBARBITUURZUURDERIVAAT, AND METHOD FOR PRODUCING 5-Substituted-5-FENYLALKYLBARBITUURZUURDERIVATEN, SUITABLE FOR USE IN SUCH PREPARATIONS.
NL149082B (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS, FORMED PREPARATIONS AND PROCESS FOR PREPARING SUITABLE THIAZOLINO (3,2-A) -5-PYRIMIDIN DERIVATIVES.
NL174044C (en) METHOD FOR PREPARING HERBICIDE THIADIAZOLYL ALKYLURUM COMPOUNDS, AND METHOD FOR PREPARING THESE COMPOUNDS CONTAINING HERBICIDE PREPARATIONS.
NL7514038A (en) PROCEDURE FOR PREPARING OCTAHYDROMORPHANTRY DERIVATIVES, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS USING THEREOF AND PREPARATIONS SO FORMED.
NL173753C (en) METHOD FOR PREPARING GONATRY DERIVATIVES, METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS AND FORMED PHARMACEUTICAL PREPARATIONS.
NL172954C (en) METHOD FOR PREPARING TRIAZOLOBENZODIAZEPINE DERIVATIVES AND METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee